Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PTPN21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TANK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OK/SW-CL.58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
TTN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DKFZP761C1711 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR29B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF385B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAG3L4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAS2R45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SH3GL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSTPIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CST3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AVIL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CLEC18A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SYCE2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on